繁體
  • 简体中文
  • 繁體中文

熱門資訊> 正文

花旗发布90天催化剂观察,Dynatrace成为焦点

2026-08-18 19:48

  • Dynatrace (DT) was in focus on Tuesday as Citi issued a 90-day catalyst watch on the AI observability company. 
  • Shares rose 1.1% in premarket trading.
  • “DT has underperformed since reporting a robust/re-accelerating F1Q27 (-6% since print; +10% YTD) and more recently following its largest acquisition to-date ($915M 22x EV/S for Arize AI),” Citi analyst Fatima Boolani wrote in a note to clients. “At [the] current 5x EV/S, 19x EV/FCF’27, DT’s not only compelling on an absolute basis, but on a relative (DDOG 11-turn/38-turn premium), and even historical basis (5-year medians 8x EV/S, 33x EV/FCF). This not only undermines solid transaction rationale, but also a faster path back to ~20% ARR CAGR [medium-term], which in aggregate warrants multiple expansion against estimate acceleration/positive revisions, in our view. Combined with an upcoming investor day (C4Q) against activist involvement (Starboard), broader software sector M&A appetite heating up (DT is a strategic asset in an attractive end-market), and a capital raise (affording potentially better repurchase optionality), we’re reaffirming Buy, lifting PT to $65 on revised CitiE (topline up [medium-term], margins lower near-term) on unchanged multiples, and initiating a positive Catalyst Watch.”

風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。